Applicability of the 2013 ACC/AHA Risk Assessment and Cholesterol Treatment Guidelines in the real world: results from a multiethnic case-control study

References

• Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129:399–410.
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–209.
   PubMed Web of Science ®Google Scholar
• Yang Z-J, Liu J, Ge J-P, Chen L, Zhao Z-G, Yang W-Y. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007–2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012;33:213–20.
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, et al. China PEACE Collaborative Group. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2014;2011:1–11.
   Google Scholar
• Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904.
   PubMed Web of Science ®Google Scholar
• Mendis S, Lindholm LH, Anderson SG, Alwan A, Koju R, Onwubere BJ, et al. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings. J Clin Epidemiol. 2011;64:1451–62.
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1–45.
   PubMed Web of Science ®Google Scholar
• Executive Summary of the Third Report (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.
   PubMed Web of Science ®Google Scholar
• Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49–73.
   PubMedGoogle Scholar
• Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382:1762–5.
   PubMed Web of Science ®Google Scholar
• Keaney JF, Curfman GD, Jarcho JA. A pragmatic view of the new cholesterol treatment guidelines. N Engl J Med. 2014;370:275–8.
   PubMed Web of Science ®Google Scholar
• Downs J, Good C. New cholesterol guidelines: has Godot finally arrived? Ann Intern Med. 2014;160:354–5.
   PubMed Web of Science ®Google Scholar
• Martin SS, Blumenthal RS. Concepts and controversies: The 2013 American College of Cardiology/American Heart Association Risk Assessment and Cholesterol Treatment Guidelines. Ann Intern Med. 2014;160:356–8.
   PubMed Web of Science ®Google Scholar
• Guallar E, Laine C. Controversy over clinical guidelines: listen to the evidence, not the noise. Ann Intern Med. 2014;160:361–2.
   PubMed Web of Science ®Google Scholar
• Psaty BM, Weiss NS. 2013 Acc/Aha guideline on the treatment of blood cholesterol: a fresh interpretation of old evidence. JAMA. 2014;311:461–2.
   PubMed Web of Science ®Google Scholar
• Ioannidis JA. More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. JAMA. 2014;311:463–4.
   PubMed Web of Science ®Google Scholar
• Montori VM, Brito JP, Ting HH. Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease. JAMA. 2014;311:465–6.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, Navar-Boggan AM, D'Agostino RB, Sr, Williams K, Neely B, Sniderman AD, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370:1422–31.
   PubMed Web of Science ®Google Scholar
• Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311:1416–23.
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Falk E. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction. BMJ Open. 2014;4:e005991.
   Google Scholar
• Ray KK, Kastelein JJ, Boekholdt SM, Nicholls SJ, Khaw KT, Ballantyne CM, et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J. 2014;35:960–8.
   PubMed Web of Science ®Google Scholar
• DeFilippis AP, Young R, Carrubba CJ, McEvoy JW, Budoff MJ, Blumenthal RS, et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162:266–75.
   PubMed Web of Science ®Google Scholar
• Cristell N, Cianflone D, Durante A, Ammirati E, Vanuzzo D, Banfi M, et al. FAMI Study Investigators. High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases. J Am Coll Cardiol. 2011;58:2654–61.
   PubMed Web of Science ®Google Scholar
• Pitt B, Loscalzo J, Ycas J, Raichlen JS. Lipid levels after acute coronary syndromes. J Am Coll Cardiol. 2008;51:1440–5.
   PubMed Web of Science ®Google Scholar
• Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel III guidelines perform? J Am Coll Cardiol. 2003;41:1475–9.
   PubMed Web of Science ®Google Scholar
• Blaha MJ, Blumenthal RS. Risk factors: new risk-assessment guidelines-more or less personalized? Nat Rev Cardiol. 2014;11:136–7.
   PubMed Web of Science ®Google Scholar
• Amin NP, Martin SS, Blaha MJ, Nasir K, Blumenthal RS, Michos ED. Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines. J Am Coll Cardiol. 2014;63:2789–94.
   PubMed Web of Science ®Google Scholar
• Navar-Boggan AM, Peterson ED, D'Agostino RB, Sr, Pencina MJ, Sniderman AD. Using age- and sex-specific risk thresholds to guide statin therapy: one size may not fit all. J Am Coll Cardiol. 2015;65:1633–9.
   PubMed Web of Science ®Google Scholar